SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Cytokine signaling in macrophages: beyond JAK-STAT

CYTOMAC aims to identify cytokine-specific transcription factors in macrophages to improve targeted therapies for inflammatory diseases by leveraging genetic diversity in mouse models.

Subsidie
€ 1.500.000
2023

Projectdetails

Introduction

Dysregulated macrophage function underlies many inflammatory diseases. Cytokines, small secreted signaling molecules with immune-modulatory functions, shape the macrophage’s phenotype, thereby affecting disease states. Puzzlingly, many cytokines with opposing functions utilize highly similar JAK-STAT signaling cascades, leaving it unclear how cytokine-specific responses can occur.

Previous Work

In my previous work, I studied enhancer activation in mouse macrophages from genetically different strains. By studying genetic variation, I found that transcription factor (TF) motifs crucial for enhancer activation can be identified. I further developed the bioinformatic tool MAGGIE to study TF motif mutations in different strains of mice, which subsequently enabled me to discover a novel TF important for enhancer activation by the cytokine interleukin-4.

Hypothesis

Based on my findings, I hypothesize that cytokines require specific, yet unidentified TFs that cooperate with JAK-STAT signaling to mount cytokine-specific effects.

Project Overview

CYTOMAC aims to identify these cytokine-specific TFs downstream of JAK-STAT that direct appropriate cell responses. I will exploit the genetic variation across mouse strains and study enhancer activation in macrophages from these strains in response to different disease-related cytokines. Specifically, I will:

  1. Use genetic diversity between mouse strains to identify specific TFs regulating cytokine-specific responses.
  2. Target these novel TFs in mouse macrophages.
  3. Target these novel TFs in human macrophages.
  4. Translate my findings to human disease and inflammatory disease models.

Clinical Relevance

Inhibitors targeting JAK-STAT show high potential in clinically treating inflammatory diseases, including rheumatoid arthritis. However, as they affect generic pathways of many cytokines, they come with considerable side effects, limiting applicability. CYTOMAC will reveal novel, cytokine-specific TFs, which will aid in developing better tailored intervention strategies.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-9-2023
Einddatum31-8-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • STICHTING AMSTERDAM UMCpenvoerder

Land(en)

Netherlands

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Negative Regulation of Inflammatory Responses Revealed with Camelid Nanobodies

The project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses.

ERC Consolid...€ 1.997.828
2024
Details

Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and Cancer

This project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets.

ERC Starting...€ 2.025.000
2022
Details

Illuminating the Dark MicroProteome in Innate Immunity

MicroIMMUNE aims to uncover the microproteome in innate immune cells using computational and synthetic biology to explore their functions and interactions, potentially revolutionizing immune response understanding.

ERC Starting...€ 1.500.000
2025
Details

Targeted Immunocytokines by CaGing and local Release

This project aims to develop and evaluate a novel, locally activated innate immune therapy for cancer that minimizes systemic toxicity while enhancing treatment efficacy.

ERC Proof of...€ 150.000
2025
Details

Targeting mechanisms of Thrombo-inflammation

This project aims to elucidate the molecular mechanisms of thrombo-inflammation through the novel TF-IFNAR1 heterodimer, potentially leading to innovative diagnostics and therapies for related diseases.

ERC Advanced...€ 2.499.000
2024
Details
ERC Consolid...

Negative Regulation of Inflammatory Responses Revealed with Camelid Nanobodies

The project aims to develop new cell biology tools to uncover intricate signaling networks that downregulate inflammation, focusing on the roles of NLRC3 and NLRX1 in controlling pro-inflammatory responses.

ERC Consolidator Grant
€ 1.997.828
2024
Details
ERC Starting...

Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and Cancer

This project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets.

ERC Starting Grant
€ 2.025.000
2022
Details
ERC Starting...

Illuminating the Dark MicroProteome in Innate Immunity

MicroIMMUNE aims to uncover the microproteome in innate immune cells using computational and synthetic biology to explore their functions and interactions, potentially revolutionizing immune response understanding.

ERC Starting Grant
€ 1.500.000
2025
Details
ERC Proof of...

Targeted Immunocytokines by CaGing and local Release

This project aims to develop and evaluate a novel, locally activated innate immune therapy for cancer that minimizes systemic toxicity while enhancing treatment efficacy.

ERC Proof of Concept
€ 150.000
2025
Details
ERC Advanced...

Targeting mechanisms of Thrombo-inflammation

This project aims to elucidate the molecular mechanisms of thrombo-inflammation through the novel TF-IFNAR1 heterodimer, potentially leading to innovative diagnostics and therapies for related diseases.

ERC Advanced Grant
€ 2.499.000
2024
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.